Ibrexafungerp: A novel oral glucan synthase inhibitor

M. R. Davis, M. A. Donnelley, G. R. Thompson

Research output: Contribution to journalReview articlepeer-review

49 Scopus citations


Dive into the research topics of 'Ibrexafungerp: A novel oral glucan synthase inhibitor'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology